投稿日：2018/04/22(日) 11:03
投稿者：Deangelo　[home]　[mail]

perfect design thanks turanaplex vs dbol Speaking at a briefing in Washington to raise awareness ofthe drug review process, Dr. Jay Siegel, head of globalregulatory affairs at Johnson & Johnson, said he expectstwo years to be knocked off the time it would typically take theFDA to review ibrutinib, the company's experimental cancer drug.